Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Healthcare Contract Research Outsourcing Market 

5.1. COVID-19 Landscape: Healthcare Contract Research Outsourcing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Healthcare Contract Research Outsourcing Market, By Type

8.1. Healthcare Contract Research Outsourcing Market, by Type, 2023-2032

8.1.1. Drug Discovery

8.1.1.1. Market Revenue and Forecast (2021-2032)

8.1.2. Pre-Clinical

8.1.2.1. Market Revenue and Forecast (2021-2032)

8.1.3. Clinical

8.1.3.1. Market Revenue and Forecast (2021-2032)

Chapter 9. Global Healthcare Contract Research Outsourcing Market, By Service

9.1. Healthcare Contract Research Outsourcing Market, by Service, 2023-2032

9.1.1. Clinical Trial Services

9.1.1.1. Market Revenue and Forecast (2021-2032)

9.1.2. Regulatory Services

9.1.2.1. Market Revenue and Forecast (2021-2032)

9.1.3. Clinical Data Management & Biometrics

9.1.3.1. Market Revenue and Forecast (2021-2032)

9.1.4. Medical Writing

9.1.4.1. Market Revenue and Forecast (2021-2032)

9.1.5. Pharmacovigilance

9.1.5.1. Market Revenue and Forecast (2021-2032)

9.1.6. Site Management Protocol

9.1.6.1. Market Revenue and Forecast (2021-2032)

9.1.7. Others

9.1.7.1. Market Revenue and Forecast (2021-2032)

Chapter 10. Global Healthcare Contract Research Outsourcing Market, By Application 

10.1. Healthcare Contract Research Outsourcing Market, by Application, 2023-2032

10.1.1. Oncology/Hematology

10.1.1.1. Market Revenue and Forecast (2021-2032)

10.1.2. Oncology/Hematology

10.1.2.1. Market Revenue and Forecast (2021-2032)

10.1.3. Autoimmune/Inflammation

10.1.3.1. Market Revenue and Forecast (2021-2032)

10.1.4. Central nervous system (CNS)

10.1.4.1. Market Revenue and Forecast (2021-2032)

10.1.5. Dermatology

10.1.5.1. Market Revenue and Forecast (2021-2032)

10.1.6. Infectious diseases

10.1.6.1. Market Revenue and Forecast (2021-2032)

10.1.7. Diabetes

10.1.7.1. Market Revenue and Forecast (2021-2032)

10.1.8. Pain

10.1.8.1. Market Revenue and Forecast (2021-2032)

10.1.9. Other

10.1.9.1. Market Revenue and Forecast (2021-2032)

Chapter 11. Global Healthcare Contract Research Outsourcing Market, By End Use 

11.1. Healthcare Contract Research Outsourcing Market, by End Use, 2023-2032

11.1.1. Pharmaceutical Companies

11.1.1.1. Market Revenue and Forecast (2021-2032)

11.1.2. Biotechnology Companies

11.1.2.1. Market Revenue and Forecast (2021-2032)

11.1.3. Medical Device Companies

11.1.3.1. Market Revenue and Forecast (2021-2032)

11.1.4. Academic Institutes & Government Organizations

11.1.4.1. Market Revenue and Forecast (2021-2032)

Chapter 12. Global Healthcare Contract Research Outsourcing Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Type (2021-2032)

12.1.2. Market Revenue and Forecast, by Service (2021-2032)

12.1.3. Market Revenue and Forecast, by Application (2021-2032)

12.1.4. Market Revenue and Forecast, by End Use (2021-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Type (2021-2032)

12.1.5.2. Market Revenue and Forecast, by Service (2021-2032)

12.1.5.3. Market Revenue and Forecast, by Application (2021-2032)

12.1.5.4. Market Revenue and Forecast, by End Use (2021-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Type (2021-2032)

12.1.6.2. Market Revenue and Forecast, by Service (2021-2032)

12.1.6.3. Market Revenue and Forecast, by Application (2021-2032)

12.1.6.4. Market Revenue and Forecast, by End Use (2021-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Type (2021-2032)

12.2.2. Market Revenue and Forecast, by Service (2021-2032)

12.2.3. Market Revenue and Forecast, by Application (2021-2032)

12.2.4. Market Revenue and Forecast, by End Use (2021-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Type (2021-2032)

12.2.5.2. Market Revenue and Forecast, by Service (2021-2032)

12.2.5.3. Market Revenue and Forecast, by Application (2021-2032)

12.2.5.4. Market Revenue and Forecast, by End Use (2021-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Type (2021-2032)

12.2.6.2. Market Revenue and Forecast, by Service (2021-2032)

12.2.6.3. Market Revenue and Forecast, by Application (2021-2032)

12.2.6.4. Market Revenue and Forecast, by End Use (2021-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Type (2021-2032)

12.2.7.2. Market Revenue and Forecast, by Service (2021-2032)

12.2.7.3. Market Revenue and Forecast, by Application (2021-2032)

12.2.7.4. Market Revenue and Forecast, by End Use (2021-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Type (2021-2032)

12.2.8.2. Market Revenue and Forecast, by Service (2021-2032)

12.2.8.3. Market Revenue and Forecast, by Application (2021-2032)

12.2.8.4. Market Revenue and Forecast, by End Use (2021-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Type (2021-2032)

12.3.2. Market Revenue and Forecast, by Service (2021-2032)

12.3.3. Market Revenue and Forecast, by Application (2021-2032)

12.3.4. Market Revenue and Forecast, by End Use (2021-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Type (2021-2032)

12.3.5.2. Market Revenue and Forecast, by Service (2021-2032)

12.3.5.3. Market Revenue and Forecast, by Application (2021-2032)

12.3.5.4. Market Revenue and Forecast, by End Use (2021-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Type (2021-2032)

12.3.6.2. Market Revenue and Forecast, by Service (2021-2032)

12.3.6.3. Market Revenue and Forecast, by Application (2021-2032)

12.3.6.4. Market Revenue and Forecast, by End Use (2021-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Type (2021-2032)

12.3.7.2. Market Revenue and Forecast, by Service (2021-2032)

12.3.7.3. Market Revenue and Forecast, by Application (2021-2032)

12.3.7.4. Market Revenue and Forecast, by End Use (2021-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Type (2021-2032)

12.3.8.2. Market Revenue and Forecast, by Service (2021-2032)

12.3.8.3. Market Revenue and Forecast, by Application (2021-2032)

12.3.8.4. Market Revenue and Forecast, by End Use (2021-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Type (2021-2032)

12.4.2. Market Revenue and Forecast, by Service (2021-2032)

12.4.3. Market Revenue and Forecast, by Application (2021-2032)

12.4.4. Market Revenue and Forecast, by End Use (2021-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Type (2021-2032)

12.4.5.2. Market Revenue and Forecast, by Service (2021-2032)

12.4.5.3. Market Revenue and Forecast, by Application (2021-2032)

12.4.5.4. Market Revenue and Forecast, by End Use (2021-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Type (2021-2032)

12.4.6.2. Market Revenue and Forecast, by Service (2021-2032)

12.4.6.3. Market Revenue and Forecast, by Application (2021-2032)

12.4.6.4. Market Revenue and Forecast, by End Use (2021-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Type (2021-2032)

12.4.7.2. Market Revenue and Forecast, by Service (2021-2032)

12.4.7.3. Market Revenue and Forecast, by Application (2021-2032)

12.4.7.4. Market Revenue and Forecast, by End Use (2021-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Type (2021-2032)

12.4.8.2. Market Revenue and Forecast, by Service (2021-2032)

12.4.8.3. Market Revenue and Forecast, by Application (2021-2032)

12.4.8.4. Market Revenue and Forecast, by End Use (2021-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Type (2021-2032)

12.5.2. Market Revenue and Forecast, by Service (2021-2032)

12.5.3. Market Revenue and Forecast, by Application (2021-2032)

12.5.4. Market Revenue and Forecast, by End Use (2021-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Type (2021-2032)

12.5.5.2. Market Revenue and Forecast, by Service (2021-2032)

12.5.5.3. Market Revenue and Forecast, by Application (2021-2032)

12.5.5.4. Market Revenue and Forecast, by End Use (2021-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Type (2021-2032)

12.5.6.2. Market Revenue and Forecast, by Service (2021-2032)

12.5.6.3. Market Revenue and Forecast, by Application (2021-2032)

12.5.6.4. Market Revenue and Forecast, by End Use (2021-2032)

Chapter 13. Company Profiles

13.1. Advanced Clinical

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Albany Molecular Research, Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Charles River Laboratories International, Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Clinipace

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Clintec

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Covance Clinical Biotech

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. CTI Clinical Trial & Consulting

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. GVK Biosciences Private Limited

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. ICON Plc

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. IQVIA HOLDINGS INC.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms